Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2010
05/27/2010US20100130494 Dermatitis treating agent (as amended)
05/27/2010US20100130493 Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancer
05/27/2010US20100130492 Morpholinopurine derivatives
05/27/2010US20100130491 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators
05/27/2010US20100130490 Csf-1r inhibitors,compositions, and methods of use
05/27/2010US20100130489 Imidazolo-heteroaryl derivatives with antibacterial properties
05/27/2010US20100130488 Pyrazolo-Pyrimidines as Casein Kinase II (CK2) Modulators
05/27/2010US20100130487 Spiro-oxindole compounds and their uses as therapeutic agents
05/27/2010US20100130486 Cyclic amine substituted pyrimidinediamines as pkc inhibitors
05/27/2010US20100130485 Cyclopropyl Amines as Modulators of the Histamine H3 Receptor
05/27/2010US20100130484 Novel bicyclic sulfonamide derivatives which are l-cpt1 inhibitors
05/27/2010US20100130483 Novel diazabicyclic aryl derivatives
05/27/2010US20100130482 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
05/27/2010US20100130481 Anticonvulsant and anxiolytic methods of using receptor subtype selective agents
05/27/2010US20100130480 Benzoquinoline inhibitors of vesicular monoamine transporter 2
05/27/2010US20100130479 Gabaergic Agents to Treat Memory Deficits
05/27/2010US20100130478 Sustained release formulations of psychoactive drugs
05/27/2010US20100130477 Spirocyclobutyl Piperidine Derivatives
05/27/2010US20100130476 Compounds that induce pancreatic beta-cell expansion
05/27/2010US20100130475 administering 7,8-dimethoxy-4(5H),10-dioxo-1H-1,2,3-triazolo[4,5-c][1]benzoazepine, a prodrug 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10-dioxo-2H-1,2,3-triazolo[4,5-c][1]benzoazepine for the treament of Crohn's disease
05/27/2010US20100130474 Alpha7 nicotinic acetylcholine receptor inhibitors
05/27/2010US20100130473 Compounds
05/27/2010US20100130472 Bile acid recycling inhibitors for treatment of obesity and diabetes
05/27/2010US20100130471 Renin Inhibitors
05/27/2010US20100130470 Acrylamide derivatives as fab i inhibitors
05/27/2010US20100130469 2, 6-naphthridine derivatives
05/27/2010US20100130468 Indole carboxamides as ikk2 inhibitors
05/27/2010US20100130467 Triazolotriazines as kinase inhibitors
05/27/2010US20100130466 Triazolyl aminopyrimidine compounds
05/27/2010US20100130465 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
05/27/2010US20100130464 Pharmaceutical compounds
05/27/2010US20100130463 6-substituted estradiol derivatives and methods of use
05/27/2010US20100130462 Lanolin compositions and methods for making and using same
05/27/2010US20100130461 Pharmaceutical composition for topical application
05/27/2010US20100130460 Topical glucocorticosteroid formulations
05/27/2010US20100130459 Neuroprotective 7-beta-hydroxysteroids
05/27/2010US20100130458 Polymorphs of fluticasone furoate and process for preparation thereof
05/27/2010US20100130457 Phenothiazine Derivatives for Treatment of Asthma
05/27/2010US20100130456 Drug Combination and Its Use in the Treatment of Muscle Loss
05/27/2010US20100130455 Bismethylene-17a carbolactones and related uses
05/27/2010US20100130454 9,10-secopregnane derivatives and medicine
05/27/2010US20100130453 Use of folates for the prevention and treatment of vascular diseases
05/27/2010US20100130452 Use of Doxycycline in the Treatment of Idiopathic Pulmonary Fibrosis
05/27/2010US20100130451 Synthesis of tetracyclines and analogues thereof
05/27/2010US20100130450 Methods of Treating Fungal Infections
05/27/2010US20100130449 Use of Tri-Substituted Glycerol Compounds for the Treatment of Radiation Injuries
05/27/2010US20100130448 3',4',5-trimethoxy flavone derivatives as stimulatn of mucus secretion, method for the same, and pharmaceutical composition comprising the same
05/27/2010US20100130447 Inhibitors of kinase activity
05/27/2010US20100130446 Nitrogen-containing five-membered heterocyclic compound
05/27/2010US20100130445 Film forming dental compositions and related methods
05/27/2010US20100130444 Complexes of prostaglandin derivatives and monosubstituted, charged beta-cyclodextrins
05/27/2010US20100130443 Chitosan derivatives, compositions and related methods of use
05/27/2010US20100130442 Lung Injury Treatment
05/27/2010US20100130441 Use of vitamin b12 for treatment of mucosal lesions
05/27/2010US20100130440 Antiviral nucleosides
05/27/2010US20100130439 Genomic mutation inhibitors that inhibit y family dna polymerases
05/27/2010US20100130438 Method for increasing oxytocin release in the epidermis
05/27/2010US20100130437 Topical antibiotic composition for the prevention of lyme disease
05/27/2010US20100130436 Co-administration of ranolazine and cardiac glycosides
05/27/2010US20100130435 Utilization of the function of rare sugar as promoter for the migration of glucokinase from nucleus to cytoplasm
05/27/2010US20100130434 Hexose Compounds to Treat Cancer
05/27/2010US20100130432 Non-Natural Amino Acids and Neurotensin Analogues Thereof
05/27/2010US20100130429 Bbs10 related diagnostic methods and reagents for bardet-biedl syndrome
05/27/2010US20100130425 Use of toll-like receptor ligands in treating excitotoxic injury, ischemia and/or hypoxia
05/27/2010US20100130422 Use of cocoa extract
05/27/2010US20100130420 Novel chimeric ligand-gated ion channels and methods of use thereof
05/27/2010US20100130418 P2X7 Inhibition Of Epithelial Cancers And Papillomas
05/27/2010US20100130417 Transforming growth factor alpha hii
05/27/2010US20100130414 Methods of Using E2F2 for the Treatment of Hypertension
05/27/2010US20100130412 Compositions to prevent and treat type-1 diabetes
05/27/2010US20100130402 Biomarkers for insulin resistance and beta-cell dysfunction
05/27/2010US20100130401 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atheroscleroris
05/27/2010US20100130359 Fungicidal Pyridazines, Processes for Their Preparation and Their Use for Controlling Harmful Fungi, and Compositions Comprising Them
05/27/2010US20100129824 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
05/27/2010US20100129496 Nutritional formulations
05/27/2010US20100129477 Composition for treatment of skin disorders
05/27/2010US20100129473 AMINO SUBSTITUTED DIARYL[a,d]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS
05/27/2010US20100129471 Iso ca-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerization
05/27/2010US20100129470 Method of treating brain cancer
05/27/2010US20100129469 Use of dimiracetam in the treatment of chronic pain
05/27/2010US20100129468 Antifungal foam containing ciclopiroxolamine and zinc pyrithione and medical and cosmetic applications thereof
05/27/2010US20100129467 Nutritional supplement
05/27/2010US20100129460 Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics
05/27/2010US20100129458 Compositions and methods for inhibiting reproduction in tadpole shrimp
05/27/2010US20100129455 Nanoparticle-dispersed fine glass beads having a cavity therein, and method of producing the same
05/27/2010US20100129452 Cellulose derivative and method for production thereof
05/27/2010US20100129451 Method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery
05/27/2010US20100129448 Topical hydrogel composition
05/27/2010US20100129447 Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
05/27/2010US20100129446 Solid dosage forms comprising an enteric coating with accelerated drug release
05/27/2010US20100129444 Novel Pharmaceutical Formulations of Modafinil
05/27/2010US20100129443 Non-abusable pharmaceutical composition comprising opioids
05/27/2010US20100129442 Oral Multi-Functional Pharmaceutical Capsule Preparations Of Proton Pump Inhibitors
05/27/2010US20100129441 Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
05/27/2010US20100129438 Methods and Compositions for the Treatment and Prevention of HIV Infection Using TRIM5ALPHA
05/27/2010US20100129437 Targeted intracellular delivery of antiviral agents
05/27/2010US20100129436 Subtances for the protection of cells and/or tissues
05/27/2010US20100129435 Methods and compositions for treatment of ocular neovascularization and neural injury
05/27/2010US20100129434 Compositions and methods for the treatment of mucormycosis and other fungal diseases
05/27/2010US20100129431 Idebenone composition for the treatment of neurological disorders
1 ... 2251 2252 2253 2254 2255 2256 2257 2258 2259 2260 2261 2262 2263 2264 2265 2266 2267 2268 2269 2270 2271 ... 7860